Trials / Completed
CompletedNCT04072315
Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/
A Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Pliant Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
A study in mild/moderate IPF patients using an αVβ6 PET ligand to evaluate target engagement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PLN-74809 | PLN-74809 |
| RADIATION | Knottin tracer | Radiotracer |
Timeline
- Start date
- 2020-02-13
- Primary completion
- 2022-06-27
- Completion
- 2022-07-05
- First posted
- 2019-08-28
- Last updated
- 2023-12-12
- Results posted
- 2023-12-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04072315. Inclusion in this directory is not an endorsement.